BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/21/2018 10:07:20 AM | Browse: 1182 | Download: 2539
 |
Received |
|
2018-08-10 05:34 |
|
Peer-Review Started |
|
2018-08-10 05:43 |
|
First Decision by Editorial Office Director |
|
2018-10-24 01:05 |
|
Return for Revision |
|
2018-10-24 08:17 |
|
Revised |
|
2018-11-26 09:17 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2018-12-06 10:01 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2018-12-07 03:33 |
|
Articles in Press |
|
2018-12-07 03:33 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2018-12-20 08:31 |
|
Publish the Manuscript Online |
|
2018-12-21 10:07 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Five years of fecal microbiota transplantation - an update of the Israeli experience
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Sharon A Greenberg, Ilan Youngster, Nathaniel A Cohen, Dan M Livovsky, Jacob Strahilevitz, Eran Israeli, Ehud Melzer, Kalman Paz, Naomi Fliss-Isakov and Nitsan Maharshak |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Nitsan Maharshak, MD, Chief Doctor, Director, Director, Doctor, Doctor, Senior Lecturer, Department of Gastroenterology and Liver Diseases & Bacteriotherapy Clinic, Tel Aviv Sourasky Medical Center, 6 Weizmann St., Tel Aviv 6423906, Israel. nitsanm@tlvmc.gov.il |
| Key Words |
Clostridium difficile infection; Capsules; Israel; Fecal microbiota transplantation |
| Core Tip |
Fecal microbiota transplantation (FMT) emerged as a promising treatment for Clostridium difficile infection (CDI). Our aim was to summarize the national Israeli experience in FMT. One-hundred and eleven patients with CDI underwent FMT, 37 (35%) of which via oral capsules and 50 (45%) via colonoscopy. The overall success rate was 87.4%, with no difference between administration routes. Success was independently related to mild disease and an ambulatory setting. One-third of the patients were younger than 60 years. 14 of which (40%) also suffered from inflammatory bowel disease. FMT is an effective treatment for recurrent CDI. FMT via capsules was shown to be a successful alternative to endoscopy. |
| Publish Date |
2018-12-21 10:07 |
| Citation |
Greenberg SA, Youngster I, Cohen NA, Livovsky DM, Strahilevitz J, Israeli E, Melzer E, Paz K, Fliss-Isakov N, Maharshak N. Five years of fecal microbiota transplantation - an update of the Israeli experience. World J Gastroenterol 2018; 24(47): 5403-5414
|
| URL |
https://www.wjgnet.com/1007-9327/full/v24/i47/5403.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v24.i47.5403 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
